RE:TransparencyThe "Korean" trial is being run by an indepependent CRO, Novotech, and, as stated in the webinar last week, Novotech won't divulge information until the trial has completed. I have already explained why patient enrollment is behind in South Korea, see my previous posts. As for the "Canadian" trial, it hasn't started yet. It is part* of the phase 2b/3 trial "international" trial, along with the U.S. and originally Australia (AUS might now be out). They just go FDA approval last week, it takes time recruiting for a trial, and you need approval first. Here's a link that might help you with your due diligence, if you read carefully, you might be surprised what you find.
https://clinicaltrials.gov/ct2/show/NCT04382924
Justforfun10 wrote: If patient enrollment has not started in the Korean and Canadian trials I think the company needs to explain why? How difficult is it to administer 3 pills per day? Are patients opting for other treatments such as Remdisivir? Are they waiting for the successful development of the IV formulation? Each week that passes by without enrollment is burning available funds.